Diverse geroprotectors differently affect a mechanism linking cellular aging to cellular quiescence in budding yeast

por Leonov, Anna, Feldman, Rachel, Piano, Amanda, Arlia-Ciommo, Anthony, Junio, Jennifer Anne Baratang, Orfanos, Emmanuel, Tafakori, Tala, Lutchman, Vicky, Mohammad, Karamat, Elsaser, Sarah, Orfali, Sandra, Rajen, Harshvardhan, Titorenko, Vladimir I.
Publicado 2022

Correction: Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II

por Mazumder, Suparna, Swank, Valerie, Komar, Anton A., Johnson, Justin M., Tuohy, Vincent K.
Publicado 2022

Addendum: A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial

por de Velasco, Guillermo, Carril-Ajuria, Lucia, Guerrero-Ramos, Felix, Alonso-Gordoa, Teresa, Rodríguez-Moreno, Juan F., Carretero, Alberto, Martin-Soberon, Maricruz, de la Rosa-Kehrmann, Federico, Castellano, Daniel
Publicado 2022

Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review

por Rubatto, Marco, Merli, Martina, Avallone, Gianluca, Agostini, Andrea, Mastorino, Luca, Caliendo, Virginia, Barcellini, Amelia, Vitolo, Viviana, Valvo, Francesca, Fierro, Maria Teresa, Ribero, Simone, Quaglino, Pietro
Publicado 2022

Addendum: Standardized diagnostic algorithm for spitzoid lesions aids clinical decision-making and management: a case series from a Swiss reference center

por Hilbers, Marie-Luise, Brändli, Regula, Mühleisen, Beda, Freiberger, Sandra N., Mangana, Joanna, Dummer, Reinhard
Publicado 2022

Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer

por Limaye, Sewanti, Kumar, Prashant, Pragya, Ramya, Sambath, Janani, Patil, Darshana, Srinivasan, Ajay, Apurva, Sachin, Srivastava, Navin, Patil, Sanket, Patil, Revati, Datta, Vineet, Akolkar, Dadasaheb, Datar, Rajan
Publicado 2022

Splice modulating oligomers as cancer therapeutics

por Chen, KuanHui E., Walker, Ameae M.
Publicado 2022

Reaching beyond family history as inclusion criteria for pancreatic cancer surveillance in high-risk populations

por Wang, Louise, Domchek, Susan M., Kochman, Michael L., Katona, Bryson W.
Publicado 2022

CDK4: a master regulator of the cell cycle and its role in cancer

por Baker, Stacey J., Poulikakos, Poulikos I., Irie, Hanna Y., Parekh, Samir, Reddy, E. Premkumar
Publicado 2022

As expected, based on rapamycin-like p53-mediated gerosuppression, mTOR inhibition acts as a checkpoint in p53-mediated tumor suppression

por Blagosklonny, Mikhail V.
Publicado 2022

Retraction: MicroRNA-182 downregulates Wnt/β-catenin signaling, inhibits proliferation, and promotes apoptosis in human osteosarcoma cells by targeting HOXA9

por Zhang, Zi-Feng, Wang, Yong-Jian, Fan, Shao-Hua, Du, Shi-Xin, Li, Xue-Dong, Wu, Dong-Mei, Lu, Jun, Zheng, Yuan-Lin
Publicado 2022

Targeted elastin-like polypeptide fusion protein for near-infrared imaging of human and canine urothelial carcinoma

por Aayush, Aayush, Darji, Saloni, Dhawan, Deepika, Enstrom, Alexander, Broman, Meaghan M., Idrees, Muhammad T., Kaimakliotis, Hristos, Ratliff, Timothy, Knapp, Deborah, Thompson, David
Publicado 2022

Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors

por Tahiri, Andliena, Puco, Katarina, Naji, Faris, Kristensen, Vessela N., Alfsen, Glenny Cecilie, Farkas, Lorant, Nilsen, Frode S., Müller, Stig, Oldenburg, Jan, Geisler, Jürgen
Publicado 2022

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

por LeBlanc, Francis R., Hasanali, Zainul S., Stuart, August, Shimko, Sara, Sharma, Kamal, Leshchenko, Violetta V., Parekh, Samir, Fu, Haiqing, Zhang, Ya, Martin, Melvenia M., Kester, Mark, Fox, Todd, Liao, Jiangang, Loughran, Thomas P., Evans, Juanita, Pu, Jeffrey J., Spurgeon, Stephen E., Aladjem, Mirit I., Epner, Elliot M.
Publicado 2022

Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the...

por Mokhtari, Reza Bayat, Qorri, Bessi, Baluch, Narges, Sparaneo, Angelo, Fabrizio, Federico Pio, Muscarella, Lucia Anna, Tyker, Albina, Kumar, Sushil, Cheng, Hai-Ling Margaret, Szewczuk, Myron R., Das, Bikul, Yeger, Herman
Publicado 2022

An ABC transporter as a potential target against SHH-Medulloblastoma: From Benchtop to Bedside

por Zhu, Jingwen, Miller, Joseph N., Schuetz, John D.
Publicado 2022

Leveraging the scientific findings to develop therapeutic strategies for dormant breast cancer cells

por Ferrer, Alejandra, Kenfack, Yannick, Petryna, Andrew, Arap, Wadih, Pasqualini, Renata, Rameshwar, Pranela
Publicado 2022

lncRNA HOTAIR functions and therapeutic perspectives

por Garbo, Sabrina, Tripodi, Marco, Battistelli, Cecilia
Publicado 2022

MicroRNAs as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much is missing?

por Gramantieri, Laura, Fornari, Francesca
Publicado 2022

Retraction: MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK

por Wang, Yong-Jian, Zhang, Zi-Feng, Fan, Shao-Hua, Zhuang, Juan, Shan, Qun, Han, Xin-Rui, Wen, Xin, Li, Meng-Qiu, Hu, Bin, Sun, Chun-Hui, Qiao, Bin, Tao, Qian, Wu, Dong-Mei, Lu, Jun, Zheng, Yuan-Lin
Publicado 2022